Grave aortic aneurysmal dilatation in DOCK8 deficiency

Modern Rheumatology

Volumn 24, Issue 4, 2014, Pages 690-693

  Al Mutairi, Muna ^a   Al Mousa, Hamoud ^a   Alsaud, Bander ^a   Hawwari, Abbas ^a   Aljoufan, Mansour ^a   Alwesaibi, Abdulkarim ^a   Alhalees, Zohair ^a   Al Mayouf, Sulaiman M ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Aneurysm; Aorta; DOCK8; Hyperimmunoglobulin E syndrome; Vasculitis

Indexed keywords

ANTIBIOTIC AGENT; PREDNISONE; DOCK8 PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR;

ANEURYSM SURGERY; ANTIBIOTIC THERAPY; AORTA ANEURYSM; AORTA ARCH; AORTA DISEASE; ARTICLE; ASCENDING AORTA; AUTOSOMAL RECESSIVE DISORDER; BRUCELLOSIS; CASE REPORT; CHICKENPOX; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DESCENDING AORTA; DOCK8 GENE; ECHOCARDIOGRAPHY; ECZEMA; GENE; GENERAL CONDITION; HUMAN; HYPERIMMUNOGLOBULINEMIA; IMMUNE DEFICIENCY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SCHOOL CHILD; SKIN ABSCESS; THORAX RADIOGRAPHY; AORTIC ANEURYSM; COMPLICATION; DEFICIENCY; HYPER IGE SYNDROME; TREATMENT OUTCOME;

AORTIC ANEURYSM; CHILD; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; JOB SYNDROME; MALE; TREATMENT OUTCOME;

EID: 84903721433     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2013.874735     Document Type: Article

References (15)

1. Paulson M, Freeman A, Holland S. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Curr Opin Allergy Clin Immunol. 2008; 8:527-33.
2. Grimbacher B, Holland S, Puck J. Hyper-IgE syndromes. Immunol Rev. 2005;203:244-50.
3. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058-62.
4. Zhang Q, Davis J, Lamborn I, Freeman A, Jing H, Favreau A, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361:2046-55.
5. Engelhardt K, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, et al. Large Deletions and point mutations involving DOCK8 in the autosomal recessive form of the Hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:1289-302.
6. Renner E, Puck J, Holland S, Schmitt M, Weiss M, Frosch M, et al. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004;144:93-9.
7. Minegishi Y, Saito M, Morio T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25: 745-55.
8. Yavuz H, Chee R. A review on the vascular features of the hyperimmunoglobulin E syndrome. Clin Exp Immunol. 2010; 159:238-44.
9. Grimbacher B, Schäffer A, Holland S, Davis J, Gallin J, Malech H, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65:735-44.
10. Freeman A, Avila E, Shaw P, Davis J, Hsu A, Welch P, et al. Coronary artery abnormalities in Hyper-IgE syndrome. J Clin Immunol. 2011;31:338-45.
11. Falah O, Thwaites S, Chalmers R. Ruptured thoracoabdominal aneurysm in a 27-year-old with hyper IgE syndrome. J Vasc Surg. 2012;55:830-2.
12. Van der meer J, Weemaes C, van Krieken J, Blomjous C, van Die C, Netea M et al. Critical aneurysmal dilatation of the thoracic aorta in young adolescents with variant Hyperimmunoglobin E syndrome. J Intern Med 2006; 259: 615-8.
13. Su H. Dedicator of cytokinesis 8 (DOCK8) deficiency. Curr Opin Allergy Clin Immunol. 2010;10:515-20.
14. Harada Y, Tanaka Y, Terasawa M, Pieczyk M, Habiro K, Katakai T, et al. DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood. 2012;119:4451-61.
15. Zhang Q, Davis J, Dove C, Su H, et al. Genetic, clinical and laboratory markers for Dock8 immunodeficiency syndrome. Dis Markers. 2010;29:131-9.